In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL.

Having started her career in pharma before the market access function existed, Jie is an industry veteran. We cover the changes she's seen over the last 24 years, including multi-stakeholder capitalisation - what it means to Jie and why she feels it's important for market access leaders.

The opinions shared in this podcast are Jie's own views.

We're kicking off 2025 with a fantastic podcast episode featuring Katrin Jack, Global Access Strategy Head at Galderma and President of the Healthcare Businesswomen's Association Zürich-Zug Chapter.

This episode covers a lot of ground, from the 'sliding doors' moment that led Katrin into market access, to why she feels it's important for leaders to understand their core values (and stay true to them).

Like many of our podcast guests, Katrin has an obvious passion for market access and it was a delight to hear about her journey and the perspectives she's gained along the way.

Bonus: In addition to the many professional insights Katrin shares in this chat, she also references the following book: "Beginner with a Black Belt" by Ana Stevanović.

The opinions shared in this podcast are Katrin's own views.

In this episode we speak with Ezgi Erdogan who is Oncology Market Access Director for Emerging Markets at GSK.

In this discussion, we cover the unpredictability of emerging markets and the unique challenges this presents. Ezgi also shares her future predictions for access in emerging markets and talks about the importance of cross-functional collaboration in pharma to support the ever-changing landscape.

The opinions shared in this podcast are Ezgi's own views.